{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:13:39Z","timestamp":1780668819383,"version":"3.54.1"},"reference-count":106,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>Working Group 1 at ISUP\u2019s Cancer Precursors meeting (September 2024) evaluated 5 putative precursors of invasive prostate cancer: high-grade prostatic intraepithelial neoplasia (HGPIN), intraductal carcinoma (IDC), atypical intraductal proliferation (AIP), atypical adenomatous hyperplasia (AAH)\/adenosis, and proliferative inflammatory atrophy (PIA). Objectives were to compile recent evidence, interrogate current practices, and vote on recommendations, with 67% approval defined as consensus. Consensus was reached against the reporting of the low-grade form of PIN. HGPIN need not be reported when concomitant cancer or atypical small acinar proliferation suspicious for cancer exists adjacent to it, for biopsy or prostatectomy specimens. Finally, while the clinical significance of unifocal HGPIN in biopsies remains uncertain, there is stronger evidence for multifocal isolated HGPIN as a predictor of subsequent cancer detection. By consensus, multifocal HGPIN should continue being reported. Slight refinement was achieved regarding IDC criteria. The consensus opinion was that a dense cribriform to solid proliferation need not demonstrate marked nuclear atypia\/ pleomorphism to qualify as IDC. The inverse scenario of marked atypia without dense cribriform\/solid proliferation fell just short (65%) of consensus for IDC. Redesignating cribriform HGPIN as AIP achieved consensus. AIP found alone or with grade group 1 cancer warrants an explanatory comment. However, agreement was not attained to report AIP in the presence of invasive cancer, in either needle biopsy or prostatectomy. Finally, the optional reporting of PIA or AAH\/adenosis in biopsies as pertinent negatives both fell short of consensus. This guidance should help pathologists standardize reporting, staying focused on the clinically actionable aspects of these lesions.<\/jats:p>","DOI":"10.1097\/pas.0000000000002430","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T04:01:38Z","timestamp":1750651298000},"page":"e33-e45","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1"],"prefix":"10.1097","volume":"49","author":[{"given":"Kenneth A.","family":"Iczkowski","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California\u2014Davis Health, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo M.","family":"De Marzo","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Urology and Oncology, The Sidney Kimmel Comprehensive Cancer Center and The James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Berman","sequence":"additional","affiliation":[{"name":"Surgery (Urology), Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Brown University, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Cimadamore","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, Queen\u2019s University, Kingston, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samson W.","family":"Fine","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Memorial Sloan-Kettering Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Greenland","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California\u2014San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Khani","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine at Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Loda","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine at Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara L.","family":"Lotan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Varma","sequence":"additional","affiliation":[{"name":"Cellular Pathology, University Hospital of Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul","family":"Chinnaiyan","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Giannarini","sequence":"additional","affiliation":[{"name":"Department of Urology, Santa Maria della Misericordia University Hospital, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoti","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Montironi","sequence":"additional","affiliation":[{"name":"Institute of Pathological Anatomy, Universit\u00e0 Politecnica delle Marche"},{"name":"Molecular Medicine and Cell Therapy Foundation, Polytechnic University of the Marche Region, Ancona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Netto","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeboye O.","family":"Osunkoya","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Urology, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Ratliff","sequence":"additional","affiliation":[{"name":"Purdue University College of Veterinary Medicine, West Lafayette, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Kristiansen","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine"},{"name":"Surgery (Urology), Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Brown University, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert J.L.H.","family":"van Leenders","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Members of the ISUP GU Cancer Precursor Consensus Panel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"R1-20251112","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0046-8177(86)80156-3","article-title":"Intraductal dysplasia: a premalignant lesion of the prostate","volume":"17","author":"McNeal","year":"1986","journal-title":"Hum Pathol"},{"key":"R2-20251112","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/1097-0142(19870215)59:4<788::AID-CNCR2820590421>3.0.CO;2-I","article-title":"Prostatic intra-epithelial neoplasia and early invasion in prostate cancer","volume":"59","author":"Bostwick","year":"1987","journal-title":"Cancer"},{"key":"R3-20251112","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2559.2011.04007.x","article-title":"Precursors of prostate cancer","volume":"60","author":"Bostwick","year":"2012","journal-title":"Histopathology"},{"key":"R4-20251112","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.humpath.2013.07.041","article-title":"Prostatic atrophy: its spatial proximity to carcinoma and intraepithelial neoplasia based on annotation of digital slides","volume":"45","author":"Iczkowski","year":"2014","journal-title":"Hum Pathol"},{"key":"R5-20251112","first-page":"2","article-title":"Introductory remarks and workshop summary","volume":"suppl. 34","author":"Drago","year":"1989","journal-title":"Urology"},{"key":"R6-20251112","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0022-5347(01)65699-4","article-title":"Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer","volume":"156","author":"Raviv","year":"1996","journal-title":"J Urol"},{"key":"R7-20251112","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00000478-200108000-00014","article-title":"Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy","volume":"25","author":"Kronz","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R8-20251112","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00428-023-03643-1","article-title":"Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer","volume":"485","author":"Martini","year":"2024","journal-title":"Virchows Arch"},{"key":"R9-20251112","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/his.14711","article-title":"WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer","volume":"81","author":"Kench","year":"2022","journal-title":"Histopathology"},{"key":"R10-20251112","first-page":"439","article-title":"High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases","volume":"8","author":"Sakr","year":"1994","journal-title":"In Vivo"},{"key":"R11-20251112","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0022-5347(01)66785-5","article-title":"The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies","volume":"154","author":"Bostwick","year":"1995","journal-title":"J Urol"},{"key":"R12-20251112","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0022-5347(05)66318-5","article-title":"Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy","volume":"165","author":"Park","year":"2001","journal-title":"J Urol"},{"key":"R13-20251112","first-page":"57","article-title":"Prostatic intraepithelial neoplasia: detection and correlation with invasive cancer in fine-needle biopsy","volume":"suppl 34","author":"Markham","year":"1989","journal-title":"Urology"},{"key":"R14-20251112","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/1097-0142(19890801)64:3<605::AID-CNCR2820640307>3.0.CO;2-I","article-title":"Beta-carotene and animal fats and their relationship to prostate cancer risk. A case-control study","volume":"64","author":"Mettlin","year":"1989","journal-title":"Cancer"},{"key":"R15-20251112","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0022-5347(01)66840-X","article-title":"Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies","volume":"154","author":"Davidson","year":"1995","journal-title":"J Urol"},{"key":"R16-20251112","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-5347(01)66601-1","article-title":"Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy","volume":"155","author":"Langer","year":"1996","journal-title":"J Urol"},{"issue":"2 Pt 1","key":"R17-20251112","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0022-5347(01)65881-6","article-title":"Repeat biopsy strategy in men with isolated prostatic intraepithelial neoplasia on prostate needle biopsy","volume":"156","author":"Shepherd","year":"1996","journal-title":"J Urol"},{"key":"R18-20251112","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0046-8177(93)90242-9","article-title":"Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy","volume":"24","author":"Weinstein","year":"1993","journal-title":"Hum Pathol"},{"key":"R19-20251112","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.pcan.4500210","article-title":"Prevalence of prostatic intra-epithelial neoplasia (PIN) in biopsies from hospital practice and pilot screening: clinical implications","volume":"1","author":"Feneley","year":"1997","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R20-20251112","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0090-4295(96)00622-X","article-title":"Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens","volume":"49","author":"Wills","year":"1997","journal-title":"Urology"},{"key":"R21-20251112","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0090-4295(99)00236-8","article-title":"Detection of high-grade prostatic intraepithelial neoplasia with the five-region biopsy technique","volume":"54","author":"Rosser","year":"1999","journal-title":"Urology"},{"key":"R22-20251112","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0022-5347(05)66351-3","article-title":"Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk","volume":"165","author":"Igel","year":"2001","journal-title":"J Urol"},{"key":"R23-20251112","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0022-5347(05)67994-3","article-title":"Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies","volume":"163","author":"Borboroglu","year":"2000","journal-title":"J Urol"},{"key":"R24-20251112","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/1097-0142(20010401)91:7<1291::AID-CNCR1131>3.0.CO;2-J","article-title":"Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race","volume":"91","author":"Fowler","year":"2001","journal-title":"Cancer"},{"key":"R25-20251112","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.pas.0000168178.48535.0d","article-title":"High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice","volume":"29","author":"Schlesinger","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R26-20251112","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/01.pas.0000213324.97294.54","article-title":"Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma","volume":"30","author":"Netto","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R27-20251112","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1158\/1078-0432.CCR-07-4987","article-title":"PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy","volume":"14","author":"Morote","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R28-20251112","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.juro.2008.10.163","article-title":"The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy","volume":"181","author":"De Nunzio","year":"2009","journal-title":"J Urol"},{"key":"R29-20251112","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2490-9-3","article-title":"Risk of prostate cancer after detection of isolated high-grade prostatic intraepithelial neoplasia (HGPIN) on extended core needle biopsy: a UK hospital experience","volume":"9","author":"Singh","year":"2009","journal-title":"BMC Urol"},{"key":"R30-20251112","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1464-410X.2009.08552.x","article-title":"Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 cases","volume":"104","author":"Hull","year":"2009","journal-title":"BJU Int"},{"key":"R31-20251112","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00345-009-0413-1","article-title":"High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on initial 21-core extended biopsy scheme: incidence and implications for patient care and surveillance","volume":"27","author":"Ploussard","year":"2009","journal-title":"World J Urol"},{"key":"R32-20251112","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.juro.2009.04.016","article-title":"Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma","volume":"182","author":"Merrimen","year":"2009","journal-title":"J Urol"},{"key":"R33-20251112","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/00313021003767306","article-title":"Is high grade prostatic intraepithelial neoplasia still a risk factor for adenocarcinoma in the era of extended biopsy sampling?","volume":"42","author":"Merrimen","year":"2010","journal-title":"Pathology"},{"key":"R34-20251112","first-page":"242","article-title":"Diagnosis of high-grade prostatic intraepithelial neoplasia: the impact of the number of biopsy cores at initial sampling on cancer detection after a saturation re-biopsy","volume":"82","author":"Roscigno","year":"2010","journal-title":"Arch Ital Urol Androl"},{"key":"R35-20251112","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.juro.2010.06.137","article-title":"Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer","volume":"184","author":"Lee","year":"2010","journal-title":"J Urol"},{"key":"R36-20251112","doi-asserted-by":"crossref","first-page":"434","DOI":"10.5489\/cuaj\/1068","article-title":"Multifocal high-grade prostatic intraepithelial neoplasia is still a significant risk factor for adenocarcinoma","volume":"4","author":"Srigley","year":"2010","journal-title":"Can Urol Assoc J"},{"key":"R37-20251112","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.urology.2010.07.519","article-title":"Long-term follow-up of men with isolated high-grade prostatic intra-epithelial neoplasia followed by serial delayed interval biopsy","volume":"77","author":"Godoy","year":"2011","journal-title":"Urology"},{"key":"R38-20251112","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.urology.2011.04.067","article-title":"Using a saturation biopsy scheme increases cancer detection during repeat biopsy in men with high-grade prostatic intra-epithelial neoplasia","volume":"78","author":"Lee","year":"2011","journal-title":"Urology"},{"key":"R39-20251112","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.urology.2003.12.029","article-title":"Monofocal and plurifocal high-grade prostatic intraepithelial neoplasia on extended prostate biopsies: factors predicting cancer detection on extended repeat biopsy","volume":"63","author":"Roscigno","year":"2004","journal-title":"Urology"},{"key":"R40-20251112","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4111\/kju.2015.56.12.796","article-title":"Multiple cores of high grade prostatic intraepithelial neoplasia and any core of atypia on first biopsy are significant predictor for cancer detection at a repeat biopsy","volume":"56","author":"Kim","year":"2015","journal-title":"Korean J Urol"},{"key":"R41-20251112","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.humpath.2018.05.011","article-title":"Initial diagnosis of insignificant cancer, high-grade prostatic intraepithelial neoplasia, atypical small acinar proliferation, and negative have the same rate of upgrade to a Gleason score of 7 or higher on repeat prostate biopsy","volume":"79","author":"Prathibha","year":"2018","journal-title":"Hum Pathol"},{"key":"R42-20251112","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s11845-021-02854-2","article-title":"Implications of a diagnosis of atypical small acinar proliferation (ASAP) and high-grade prostatic intraepithelial neoplasia (HGPIN) on prostate biopsy: a 5-year follow-up study","volume":"191","author":"O\u2019Connor","year":"2022","journal-title":"Ir J Med Sci"},{"key":"R43-20251112","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/JU.0000000000003492","article-title":"Early detection of prostate cancer: AUA\/SUO Guideline Part II: considerations for a prostate biopsy","volume":"210","author":"Wei","year":"2023","journal-title":"J Urol"},{"key":"R44-20251112","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0022-5347(05)67811-1","article-title":"Strategy for repeat biopsy in patients with high grade prostatic intraepithelial neoplasia","volume":"163","author":"Kamoi","year":"2000","journal-title":"J Urol"},{"key":"R45-20251112","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0090-4295(01)01436-4","article-title":"Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling?","volume":"58","author":"Lefkowitz","year":"2001","journal-title":"Urology"},{"key":"R46-20251112","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1464-410X.2006.06728.x","article-title":"The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer","volume":"99","author":"Schoenfield","year":"2007","journal-title":"BJU Int"},{"key":"R47-20251112","doi-asserted-by":"crossref","first-page":"432.e11","DOI":"10.1016\/j.urolonc.2020.10.016","article-title":"Prediction of clinically significant prostate cancer after negative prostate biopsy: the current value of microscopic findings","volume":"39","author":"Morote","year":"2021","journal-title":"Urol Oncol"},{"key":"R48-20251112","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0090-4295(00)00447-7","article-title":"Analysis of repeated biopsy results within 1 year after a noncancer diagnosis","volume":"55","author":"O\u2019Dowd","year":"2000","journal-title":"Urology"},{"key":"R49-20251112","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1464-410X.2003.04081.x","article-title":"Clinical management of prostatic intraepithelial neoplasia as diagnosed by extended needle biopsies","volume":"91","author":"San Francisco","year":"2003","journal-title":"BJU Int"},{"key":"R50-20251112","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00000478-200405000-00010","article-title":"High-grade prostatic intraepithelial neoplasia on needle biopsy: risk of cancer on repeat biopsy related to number of involved cores and morphologic pattern","volume":"28","author":"Bishara","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R51-20251112","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1464-410X.2004.04996.x","article-title":"Predictors of prostate cancer on extended biopsy in patients with high-grade prostatic intraepithelial neoplasia: a multivariate analysis model","volume":"94","author":"Abdel-Khalek","year":"2004","journal-title":"BJU Int"},{"key":"R52-20251112","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/pros.20105","article-title":"Lesions predictive for prostate cancer in a screened population: first and second screening round findings","volume":"61","author":"Postma","year":"2004","journal-title":"Prostate"},{"key":"R53-20251112","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.urology.2004.10.010","article-title":"High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population","volume":"65","author":"Gokden","year":"2005","journal-title":"Urology"},{"key":"R54-20251112","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.humpath.2014.03.011","article-title":"Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion","volume":"45","author":"Miyai","year":"2014","journal-title":"Hum Pathol"},{"key":"R56-20251112","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/1940-6207.CAPR-15-0431","article-title":"Premalignancy in prostate cancer: rethinking what we now","volume":"9","author":"De Marzo","year":"2016","journal-title":"Cancer Prev Res (Phila)"},{"key":"R57-20251112","doi-asserted-by":"crossref","first-page":"a030403","DOI":"10.1101\/cshperspect.a030403","article-title":"Molecular pathology of high-grade prostatic intraepithelial neoplasia: challenges and opportunities","volume":"9","author":"Trabzonlu","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R59-20251112","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005392-199707000-00004","article-title":"The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues","volume":"158","author":"H\u00e4ggman","year":"1997","journal-title":"J Urol"},{"key":"R60-20251112","first-page":"366","article-title":"Quantitative analysis of prostatic intraepithelial neoplasia on tissue sections","volume":"12","author":"Montironi","year":"1990","journal-title":"Anal Quant Cytol Histol"},{"key":"R61-20251112","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.eururo.2015.10.031","article-title":"Genetic progression of high grade prostatic intraepithelial neoplasia to prostate cancer","volume":"69","author":"Jung","year":"2016","journal-title":"Eur Urol"},{"key":"R62-20251112","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.ajpath.2010.12.040","article-title":"Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene","volume":"178","author":"Koh","year":"2011","journal-title":"Am J Pathol"},{"key":"R63-20251112","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/modpathol.2008.111","article-title":"Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis","volume":"21","author":"Gurel","year":"2008","journal-title":"Mod Pathol"},{"key":"R64-20251112","first-page":"2959","article-title":"Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia","volume":"55","author":"Emmert-Buck","year":"1995","journal-title":"Cancer Res"},{"key":"R65-20251112","first-page":"6405","article-title":"Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis","volume":"62","author":"Meeker","year":"2002","journal-title":"Cancer Res"},{"key":"R66-20251112","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/mc.23009","article-title":"Molecular evidence supporting the precursor nature of atypical adenomatous hyperplasia of the prostate","volume":"58","author":"Cheng","year":"2019","journal-title":"Mol Carcinog"},{"key":"R67-20251112","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/sj.onc.1206227","article-title":"Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma","volume":"22","author":"Vukovic","year":"2003","journal-title":"Oncogene"},{"key":"R68-20251112","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/path.4980","article-title":"MYC drives overexpression of telomerase RNA (hTR\/TERC) in prostate cancer","volume":"244","author":"Baena-Del Valle","year":"2018","journal-title":"J Pathol"},{"key":"R69-20251112","doi-asserted-by":"crossref","first-page":"e169868","DOI":"10.1172\/jci.insight.169868","article-title":"MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression","volume":"8","author":"Chen","year":"2023","journal-title":"JCI Insight"},{"key":"R70-20251112","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/01.pas.0000213424.38503.aa","article-title":"TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion","volume":"31","author":"Perner","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R71-20251112","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1200\/JCO.2013.49.8386","article-title":"TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia","volume":"32","author":"Park","year":"2014","journal-title":"J Clin Oncol"},{"key":"R72-20251112","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.humpath.2017.04.024","article-title":"PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform","volume":"65","author":"Ronen","year":"2017","journal-title":"Hum Pathol"},{"key":"R73-20251112","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.humpath.2016.04.017","article-title":"ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma","volume":"55","author":"Morais","year":"2016","journal-title":"Hum Pathol"},{"key":"R74-20251112","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1158\/1541-7786.MCR-16-0246","article-title":"Novel assay to detect RNA polymerase I activity in vivo","volume":"15","author":"Guner","year":"2017","journal-title":"Mol Cancer Res"},{"key":"R75-20251112","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12253-016-0119-9","article-title":"SPINK1 overexpression in localized prostate cancer: a rare event inversely associated with ERG expression and exclusive of homozygous PTEN deletion","volume":"23","author":"Huang","year":"2017","journal-title":"Pathol Oncol Res"},{"key":"R76-20251112","doi-asserted-by":"crossref","first-page":"a030445","DOI":"10.1101\/cshperspect.a030445","article-title":"Prostate cancer epigenetics: from basic mechanisms to clinical implications","volume":"9","author":"Yegnasubramanian","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R77-20251112","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/path.1503","article-title":"Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia","volume":"202","author":"Kang","year":"2004","journal-title":"J Pathol"},{"key":"R78-20251112","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0002-9440(10)63452-9","article-title":"Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection","volume":"163","author":"Nakayama","year":"2003","journal-title":"Am J Pathol"},{"key":"R79-20251112","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1158\/1940-6207.CAPR-22-0485","article-title":"Progressive Spreading of DNA methylation in the GSTP1 promoter CpG island across transitions from precursors to invasive prostate cancer","volume":"16","author":"Gupta","year":"2023","journal-title":"Cancer Prev Res (Phila)"},{"key":"R80-20251112","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/1078-0432.CCR-04-0894","article-title":"Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker","volume":"10","author":"Jer\u00f3nimo","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R81-20251112","first-page":"247","article-title":"DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas","volume":"15","author":"Berner","year":"1993","journal-title":"Anal Quant Cytol Histol"},{"key":"R83-20251112","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/1097-0142(19851001)56:7<1566::AID-CNCR2820560717>3.0.CO;2-Y","article-title":"Ductal spread in prostatic carcinoma","volume":"56","author":"Kovi","year":"1985","journal-title":"Cancer"},{"key":"R84-20251112","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/00000478-199607000-00003","article-title":"Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations","volume":"20","author":"McNeal","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R85-20251112","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/modpathol.3800702","article-title":"Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance","volume":"19","author":"Guo","year":"2006","journal-title":"Mod Pathol"},{"key":"R86-20251112","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/PAS.0000000000001776","article-title":"Intraductal carcinoma of the prostate: extreme nuclear size is not a diagnostic parameter","volume":"45","author":"Samaratunga","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R87-20251112","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/PAS.0000000000000794","article-title":"Atypical intraductal cribriform proliferations of the prostate exhibit similar molecular and clinicopathologic characteristics as intraductal carcinoma of the prostate","volume":"41","author":"Hickman","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R88-20251112","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/1097-0045(20000901)44:4<265::AID-PROS1>3.0.CO;2-I","article-title":"Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression","volume":"44","author":"Dawkins","year":"2000","journal-title":"Prostate"},{"key":"R89-20251112","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/gcc.20560","article-title":"Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate","volume":"47","author":"Bettendorf","year":"2008","journal-title":"Genes Chromosom Cancer"},{"key":"R90-20251112","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/modpathol.2012.201","article-title":"Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia","volume":"26","author":"Lotan","year":"2013","journal-title":"Mod Pathol"},{"key":"R91-20251112","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/his.13273","article-title":"Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand the morphological spectrum of intraductal carcinoma","volume":"71","author":"Shah","year":"2017","journal-title":"Histopathology"},{"key":"R92-20251112","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/PAS.0b013e3181d6827b","article-title":"ETS gene aberrations in atypical cribriform lesions of the prostate: implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia","volume":"34","author":"Han","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R93-20251112","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/path.5283","article-title":"Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations","volume":"249","author":"Khani","year":"2019","journal-title":"J Pathol"},{"key":"R94-20251112","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/path.4628","article-title":"Molecular evidence that invasive adenocarcinoma can mimic PIN and intraductal carcinoma through retrograde glandular colonization","volume":"238","author":"Haffner","year":"2016","journal-title":"J Pathol"},{"key":"R95-20251112","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.eururo.2014.09.006","article-title":"Tracking the origin of metastatic prostate cancer","volume":"67","author":"Lindberg","year":"2015","journal-title":"Eur Urol"},{"key":"R96-20251112","doi-asserted-by":"crossref","first-page":"13671","DOI":"10.1038\/ncomms13671","article-title":"Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories","volume":"8","author":"Taylor","year":"2017","journal-title":"Nat Commun"},{"key":"R97-20251112","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/1541-7786.MCR-18-0440","article-title":"Genetic and epigenetic determinants of aggressiveness in cribriform carcinoma of the prostate","volume":"17","author":"Elfandy","year":"2019","journal-title":"Mol Cancer Res"},{"key":"R98-20251112","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","article-title":"The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer","volume":"145","author":"Epstein","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"R99-20251112","first-page":"810","article-title":"Intraductal carcinoma of the prostate: conflicting recommendations confuse clinicians","volume":"77","author":"Varma","year":"2024","journal-title":"J Clin Pathol"},{"key":"R100-20251112","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/his.14179","article-title":"Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens","volume":"77","author":"Rijstenberg","year":"2020","journal-title":"Histopathology"},{"key":"R101-20251112","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.anndiagpath.2014.08.010","article-title":"Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists","volume":"18","author":"Iczkowski","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"R102-20251112","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/PAS.0b013e3181cfc44b","article-title":"Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies","volume":"34","author":"Shah","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R103-20251112","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/his.13878","article-title":"Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes","volume":"75","author":"Shah","year":"2019","journal-title":"Histopathology"},{"key":"R104-20251112","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/PAS.0000000000000348","article-title":"Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy","volume":"39","author":"Morais","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R106-20251112","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1097\/PAS.0b013e318294e9bc","article-title":"Atypical adenomatous hyperplasia of prostate lacks TMPRSS2-ERG gene fusion","volume":"37","author":"Cheng","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R107-20251112","first-page":"389","article-title":"Atypical adenomatous hyperplasia of the prostate: a premalignant lesion?","volume":"58","author":"Cheng","year":"1998","journal-title":"Cancer Res"},{"key":"R108-20251112","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0002-9440(10)64286-1","article-title":"Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy","volume":"162","author":"Van Leenders","year":"2003","journal-title":"Am J Pathol"},{"key":"R109-20251112","doi-asserted-by":"crossref","first-page":"e2018976118","DOI":"10.1073\/pnas.2018976118","article-title":"Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancer","volume":"118","author":"Shrestha","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R110-20251112","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.6149","article-title":"Club-like cells in proliferative inflammatory atrophy of the prostate","volume":"261","author":"Huang","year":"2023","journal-title":"J Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:00:49Z","timestamp":1762927249000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002430"}},"subtitle":["The Prostate"],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":106,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002430","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]}}}